Morgan Stanley discloses 8.4% stake in Klaviyo on Schedule 13G
Rhea-AI Filing Summary
Morgan Stanley filed a Schedule 13G reporting beneficial ownership in Klaviyo, Inc. (KVYO) Series A Common Stock. The filing lists 10,321,920 shares beneficially owned, representing 8.4% of the class as of the 09/30/2025 event date. The firm reports 0 shares with sole voting or dispositive power, 6,785,764 shares with shared voting power, and 10,321,920 shares with shared dispositive power.
Morgan Stanley certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The reporting person is identified as a Delaware entity (Type: HC, CO), referencing CUSIP 49845K101. The issuer’s principal office is listed in Boston, MA.
Positive
- None.
Negative
- None.
FAQ
What stake did Morgan Stanley report in Klaviyo (KVYO)?
What voting and dispositive powers were disclosed for KVYO?
What is the Date of Event for Morgan Stanley’s 13G on KVYO?
What certification accompanies the 13G filing for KVYO?
What class and CUSIP were reported for Klaviyo in this 13G?
Who is the reporting person and where are they organized?